SCANLY
DEAD

Serial Number

90289002

Owner

NotalVision, Inc.

Attorney

Manuel Valcarcel, Esq.

Filing Date

Oct 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SCANLY Trademark

Serial Number: 90289002

SCANLY is a trademark filed by NotalVision, Inc. on October 30, 2020. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NotalVision, Inc. (4 trademarks)

7717 COPPERMINE DRIVE
MANASSAS, VA 20109

Entity Type: 03

Notal Vision Inc. (19 trademarks)

Manassas, VA 20109

Entity Type: 03

Trademark Details

Filing Date

October 30, 2020

Registration Date

Not Registered

Published for Opposition

October 12, 2021

Goods & Services

Medical services, namely, vision care services and eye care services; provision of optical medical services, ophthalmic services, and ophthalmic diagnostic services; patient rehabilitation care services; medical consultations in the nature of provision of medical second opinions; information, advisory and consultancy services relating to all of the aforementioned services; providing information relating to ophthalmic services and ophthalmic diagnostic services; providing a website and online computer database featuring vision care and eye care, optical and ophthalmic medical information for use by medical and healthcare service providers and patients; providing patient-specific medical information to healthcare professionals

Medical devices, apparatus, instruments and equipment for the viewing, detection, diagnosis, management and treatment of retinal diseases, namely, macular degeneration, diabetic macular edema (DME), retinal vein occlusion(RVO), high Myopia and Glaucoma; medical devices, apparatus, instruments, and equipment for the viewing, detection, diagnosis, management and treatment of macular degeneration, diabetic macular edema (DME), retinal vein occlusion (RVO), high Myopia and Glaucoma and other eye conditions and diseases; optical coherence tomography devices and equipment for home use; medical devices, apparatus, instruments, and equipment for monitoring progression of eye conditions and diseases and in particular for use in the detection and characterization of patients with age-related macular degeneration, diabetic macular edema (DME), retinal vein occlusion (RVO), high Myopia and Glaucoma; and parts and fittings for all the aforementioned goods

Software as a service (SAAS) services, namely, hosting a cloud-based platform that allows for uploading and analyzing test results; Software as a service (SAAS) services featuring non-downloadable software and proprietary algorithms for analyzing optical coherence tomography imaging; Providing online, non-downloadable software allowing for interactive communications and exchange of information between healthcare professionals and patients; Providing online, non-downloadable software for healthcare professionals to receive and provide patient-specific information; Providing online, non-downloadable software for use by medical and healthcare service providers and patients in accessing an online computer database conveying information in the fields of vision care and eye care, optical and ophthalmic medical information; Providing a website featuring online, non-downloadable software for use by medical and healthcare service providers and patients in accessing an online computer database conveying information in the fields of vision care and eye care, optical and ophthalmic medical information

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2024 EXRA
SOU EXTENSION 5 GRANTED
May 20, 2024 EX5G
SOU EXTENSION 5 FILED
May 20, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
May 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 24, 2023 EXRA
SOU EXTENSION 4 GRANTED
Nov 22, 2023 EX4G
SOU EXTENSION 4 FILED
Nov 22, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2023 EXRA
SOU EXTENSION 3 GRANTED
May 9, 2023 EX3G
SOU EXTENSION 3 FILED
May 9, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
May 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 16, 2022 EXRA
SOU EXTENSION 2 GRANTED
Nov 14, 2022 EX2G
SOU EXTENSION 2 FILED
Nov 14, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 14, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2022 EXRA
SOU EXTENSION 1 GRANTED
Apr 26, 2022 EX1G
SOU EXTENSION 1 FILED
Apr 26, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 26, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 7, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 4, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 4, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 4, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 4, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2021 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 31, 2021 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 24, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2020 NWOS
NEW APPLICATION ENTERED
Nov 3, 2020 NWAP